IL1B and new-onset refractory status epilepticus: Similarly, anakinra, an IL-1 antagonist, has been shown to be effective in reducing seizure activity and seizure recurrence in two case reports of NORSE; however, it did not prevent brain atrophy, which may be related to late administration of the drug in both reports or additional pathological processes related to SE or NORSE [225,226].